脂肪酸結(jié)合蛋白1(FABP1)單克隆抗體
Monoclonal Antibody to Fatty Acid Binding Protein 1 (FABP1)
FABP-1; FABPL; L-FABP; LFABP; Liver-type fatty acid-binding protein; Fatty Acid Binding Protein 1, Liver
- 編號(hào)UMAB566Hu21
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(jià)(克隆號(hào))2#
- Ig亞型 IgG2b Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 RPB566Hu01-脂肪酸結(jié)合蛋白1(FABP1)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度1mg/mL
- 且適物種Rattus norvegicus (Rat，大鼠), Sus scrofa; Porcine (Pig，豬)
- 應(yīng)用WB; IHC
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 335 ¥ 781 ¥ 1116 ¥ 2790 ¥ 11160
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P;
Sample: Rat Liver Tissue
Primary Ab: 30μg/ml Mouse Anti-Human FABP1 Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
Figure. Western Blot; Sample: Recombinant FABP1, Human.
-
Western Blot; Sample: Human Liver lysate;
Primary Ab: 1μg/mL Mouse Anti-Human FABP1 Antibody
Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
Western Blot; Samples: Lane1: Porcine Liver lysate; Lane2: Porcine Small intestine lysate;
Primary Ab: 0.2μg/ml Mouse Anti-Human FABP1 Antibody
Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
Western Blot; Samples: Lane1: HUH7 cell lysate; Lane2: Fetal Rat Liver lysate;
Primary Ab: 0.2μg/ml Mouse Anti-Human FABP1 Antibody
Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對(duì)FABP1的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別FABP1。
用法
Western blotting: 0.5-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長(zhǎng)臂生物素標(biāo)記試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPB566Hu01 | 脂肪酸結(jié)合蛋白1(FABP1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAB566Hu01 | 脂肪酸結(jié)合蛋白1(FABP1)多克隆抗體 | WB; IHC |
| UPAB566Hu02 | 脂肪酸結(jié)合蛋白1(FABP1)多克隆抗體 | IHC |
| ULAB566Hu71 | 脂肪酸結(jié)合蛋白1(FABP1)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| ULAB566Hu81 | 脂肪酸結(jié)合蛋白1(FABP1)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| UMAB566Hu22 | 脂肪酸結(jié)合蛋白1(FABP1)單克隆抗體 | WB; IHC; ICC/IF |
| UMAB566Hu23 | 脂肪酸結(jié)合蛋白1(FABP1)單克隆抗體 | IHC |
| UMAB566Hu21 | 脂肪酸結(jié)合蛋白1(FABP1)單克隆抗體 | WB; IHC |
| ULAB566Hu82 | 脂肪酸結(jié)合蛋白1(FABP1)單克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| ULAB566Hu72 | 脂肪酸結(jié)合蛋白1(FABP1)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| UHEB566Hu | 脂肪酸結(jié)合蛋白1(FABP1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| UWEB566Hu | 脂肪酸結(jié)合蛋白1(FABP1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,寬范圍) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| USEB566Hu | 脂肪酸結(jié)合蛋白1(FABP1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMB566Hu | 脂肪酸結(jié)合蛋白1(FABP1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| UPSB566Hu01 | 脂肪酸結(jié)合蛋白1(FABP1)抗體對(duì) | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| UKSB566Hu01 | 脂肪酸結(jié)合蛋白1(FABP1)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | 自己動(dòng)手制作ELISA試劑盒的主要材料 |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| J Korean Med Sci. | Acute Kidney Injury after Using Contrast during Cardiac Catheterization in Children with Heart Disease [Pubmed:25120320] |
| Cryobiology.? | Ex vivo use of a Rho-kinase inhibitor during renal preservation improves graft function upon reperfusion [Pubmed:25555715] |
| Clin Transl Sci | Controlled Rewarming after Hypothermia: Adding a New Principle to Renal Preservation [PubMed: 26053383] |
| SAGE journals | The role of serum I-FABP concentration in assessment of small intestine mucosa among HIV-infected patients [Content: Early] |
| Transplant International | Kidney transplantation after oxygenated machine perfusion preservation with Custodiol‐N solution [PubMed: 25882869] |
| European?Journal of?Clinical?Investigation | Prediction of renal function upon reperfusion by ex situ controlled oxygenated rewarming [pubmed:27718228] |
| Journal of?Clinical?and Diagnostic?Research? | The Importance of Liver-Fatty Acid Binding Protein in Diagnosis of Liver Damage in Patients with Acute Hepatitis [pubmed:28571184] |
| Annals of Nutrition and Metabolism | Plasma Free Fatty Acids and their Binding Proteins in Preterm Infants [Pubmed:30045009] |
| Scandinavian Journal of?Clinical?and Laboratory Investigation | Isolated kidney perfusion: the influence of pulsatile flow [Pubmed:29301417] |
| International Journal of Medical Sciences | Circulating fatty acid-binding protein 1 (FABP1) and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus [Pubmed: 32038102] |
| International Journal of Medical Sciences | FABP1 and FABP2 as markers of diabetic nephropathy [Pubmed: 32922200] |
| Archives of Clinical and Biomedical Research | Profile of Intestinal Barrier Functional Markers in Italian Patients with Diarrhea-Predominant IBS: Preliminary Data from a Low-FODMAPs diet Trial [] |
| Antioxidants | The Effects of Beverage Intake after Exhaustive Exercise on Organ Damage, Inflammation and Oxidative Stress in Healthy Males [34071378] |
| antioxidants | TCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled Hypertension [34356333] |
| Association of plasma fatty acid-binding protein 3 with estimated glomerular filtration rate in patients with type 2 diabetes mellitus [34975301] |
